Drugs for Bone Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 263)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Buprenorphine |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
52485-79-7, 53152-21-9 |
644073 40400 |
Synonyms:
(−)-buprenorphine
(-)-Buprenorphine
17-Cyclopropylmethyl-4,5a-epoxy-7a-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5a-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6a-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-Cyclopropyl-7a-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
ALKS-5461 COMPONENT BUPRENORPHINE
BUPEAZE
BUPLAST
Buprel
Buprenex
Buprenex®|Buvidal®|CAM2038|Sixmo® (buprenorphine hydrochloride)|Subutex®|Temgesic®
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
BUPRENORPHINE
Buprenorphine grünenthal brand
Buprenorphine Hcl
Buprenorphine hydrochloride
Buprenorphinum
Buprenorphinum [INN-Latin]
Buprex
|
BUTEC
BUTRANS
Essex brand OF buprenorphine hydrochloride
Grünenthal brand OF buprenorphine
Grünenthal brand OF buprenorphine hydrochloride
HAPOCTASIN
Hydrochloride, buprenorphine
Key brand OF buprenorphine hydrochloride
PANITAZ
Prefin
PRENOTRIX
Probuphine
Reckitt and colman brand 1 OF buprenorphine hydrochloride
Reckitt and colman brand 2 OF buprenorphine hydrochloride
Reckitt benckiser brand OF buprenorphine hydrochloride
Reckitt brand OF buprenorphine hydrochloride
RELETRANS
RX 6029 m
RX-6029-m
Schering plough brand OF buprenorphine hydrochloride
Schering-plough brand OF buprenorphine hydrochloride
SEVODYNE
SUBLOCADE
Subutex
Temgesic
Temgésic
TEPHINE
TRANSTEC
|
|
2 |
|
Methadone |
Approved |
Phase 4 |
|
76-99-3, 1095-90-5 |
4095 |
Synonyms:
(±)-methadone|dl-methadone|Dolophine HCL®|methadone HCl|Methadose®
(+-)-Methadone
(+/-)-methadone
(+/-)-methadone hydrochloride
(±)-methadone
6-(Dimethylamino)-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-Diphenyl-3-heptanone
Adanon
Adanon hydrochloride
AddiCare brand OF methadone hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose hydrochloride
Amidon
Amidone
Biodone
Biomet brand OF methadone hydrochloride
Biscuits
Butalgin
Depridol
Diaminon
Diaminon hydrochloride
DL-Methadone
DL-Methadone hydrochloride
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine HCL
Esteve brand OF methadone hydrochloride
Fenadon
Fenadone
Generics brand OF methadone hydrochloride
GlaxoSmithKline brand OF methadone hydrochloride
HEPTADON
Heptadone
|
Heptanon
Hydrochloride, methadone
IDS-NM-002
Ketalgin
Ketalgin hydrochloride
Mallinckrodt brand OF methadone hydrochloride
Martindale brand OF methadone hydrochloride
Mecodin
Mephenon
Metadol
Metadona
Metasedin
Methaddict
Methadon
METHADONE
Methadone HCL
Methadone HCL Intensol
Methadone hydrochloride
Methadone M
Methadonum
Methadose
Methaquaione
Methex
Miadone
Moheptan
Pharmascience brand OF methadone hydrochloride
Phenadone
Phenadone hydrochloride
PHY
Phymet
Physeptone
Pinadone
Pinewood brand OF methadone hydrochloride
Polamidon
Polamidone
Rosemont brand OF methadone hydrochloride
Roxane brand OF methadone hydrochloride
Symoron
Tussol
WESTADONE
Yamanouchi brand OF methadone hydrochloride
|
|
3 |
|
Velpatasvir |
Approved, Investigational |
Phase 4 |
|
1377049-84-7 |
77335690 67683363 |
Synonyms:
|
4 |
|
Sofosbuvir |
Approved |
Phase 4 |
|
1190307-88-0 |
45375808 |
Synonyms:
GI 7977
GI-7977
GS7977
GS-7977
ISOPROPYL (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL]METHOXY}(PHENOXY)PHOSPHORYL]AMINO}PROPANOATE
PSI 7977
|
PSI-7977
PSI-7977, GS-7977
S)-ISOPROPYL 2-((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)- (PHENOXY)PHOSPHORYLAMINO)PROPANOATE
SOFOSBUVIR
SOVALDI
|
|
5 |
|
Cobicistat |
Approved |
Phase 4 |
|
1004316-88-4 |
24950485 25151504 |
Synonyms:
1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-({[(2-ISOPROPYL-1,3-THIAZOL-4-YL)METHYL](METHYL)CARBAMOYL}AMINO)-4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE
COBICISTAT
GS 9350
|
GS-9350
N-[5-({hydroxy[(1,3-thiazol-5-yl)methoxy]methylidene}amino)-1,6-diphenylhexan-2-yl]-2-(N-methyl-N-{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}-(C-hydroxycarbonimidoyl)amino)-4-(morpholin-4-yl)butanimidate
TYBOST
|
|
6 |
|
Elvitegravir |
Approved |
Phase 4 |
|
697761-98-1 |
23083982 5277135 |
Synonyms:
6-(3-CHLORO-2-FLUOROBENZYL)-1-[(2S)-1-HYDROXY-3-METHYLBUTAN-2-YL]-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
ABBR evg
ELVITEGRAVIR
ELVITÉGRAVIR
EVG
|
GS 9137
GS-9137
JTK-303
Vitekta
|
|
7 |
|
Naloxone |
Approved, Vet_approved |
Phase 4 |
|
465-65-6 |
5284596 |
Synonyms:
(-)-Naloxone
(−)-NALOXONE
(-)-naloxone|Kloxxado® (naloxone hydrochloride nasal spray)|l-naloxone|Narcan®|Nyxoid®
[<i>N</i>-allyl-2,3-<sup>3</sup>H]naloxone
17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
Abello brand OF naloxone hydrochloride
Abello, naloxone
Boots brand OF naloxone hydrochloride
Bristol myers squibb brand OF naloxone hydrochloride
Bristol-myers squibb brand OF naloxone hydrochloride
Curamed brand OF naloxone hydrochloride
Curamed, naloxon
DBL Naloxone
Dihydride, naloxone hydrochloride
EN 1530 base
endo Brand OF naloxone hydrochloride
Hydrobromide, naloxone
Hydrochloride dihydride, naloxone
Hydrochloride, naloxone
Lamepro brand OF naloxone hydrochloride
L-Naloxone
MRZ 2593 BR
MRZ 2593BR
MRZ 2593-BR
N-Allylnoroxymorphone
|
Nalone
Nalossone
Nalossone [Dcit]
Naloxon curamed
Naloxon ratiopharm
Naloxona
Naloxona [INN-Spanish]
NALOXONE
Naloxone abello
Naloxone HCl
Naloxone hydrobromide
Naloxone hydrochloride
Naloxone hydrochloride dihydride
Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxonratiopharm
Naloxon-ratiopharm
Naloxonum
Naloxonum [INN-Latin]
Narcan
Narcanti
Narcon
NSC-70413
Ratiopharm brand OF naloxone hydrochloride
SERB brand OF naloxone hydrochloride
SUBOXONE
United drug brand OF naloxone hydrochloride
|
|
8 |
|
Potassium citrate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
866-84-2 |
|
Synonyms:
Potassium citrate anhydrous
Potassium citric acid
|
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
Tripotassium citrate
|
|
9 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
10 |
|
Ethinylestradiol |
Approved |
Phase 4 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
11 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
12 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
13 |
|
Risedronic acid |
Approved, Investigational |
Phase 4 |
|
105462-24-6 |
5245 |
Synonyms:
1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidenebisphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidene-bisphosphonate
Acid, risedronic
Acide risédroniqe
Acido risedronico
Acidum risedronicum
Actonel
Actonel 150
Actonel®|Atelvia®|NE-58095|risedronate sodium
Atelvia
Benet
Bisphosphate risedronate sodium
Bisphosphonate risedronate sodium
|
M05BA07
NE-58095
Ridron
Risedronate
Risedronate sodium
Risedronate sodium, bisphosphate
Risedronate sodium, bisphosphonate
Risedronic acid
Risedronic acid, monosodium salt
Risedronsäure
Sodium, bisphosphate risedronate
Sodium, bisphosphonate risedronate
Sodium, risedronate
|
|
14 |
|
Ibandronate |
Approved, Investigational |
Phase 4 |
|
114084-78-5 |
60852 |
Synonyms:
(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate
ácido ibandrónico
Bondronat
Bondronat®|Boniva®|ibandronate
Boniva
Bonviva
IASIBON
|
IBANDRONATE
Ibandronate sodium
Ibandronate sodium anhydrous
Ibandronate sodium monohydrate
Ibandronic acid
Ibandronic acid, sodium salt, monohydrate
QUODIXOR
R484
|
|
15 |
|
Tibolone |
Approved, Investigational |
Phase 4 |
|
5630-53-5 |
5470 444008 |
Synonyms:
17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one
Boltin|Livial|Org OD 14|Tibofem
LIVIAL
ORG OD 14
|
ORG-OD 14
tibolona
TIBOLONE
tibolonum
|
|
16 |
|
Lactulose |
Approved |
Phase 4 |
|
4618-18-2 |
11333 |
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)TETRAHYDROFURAN-3-YL]OXY-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-DIMETHYLOL-TETRAHYDROFURAN-3-YL]OXY-6-METHYLOL-TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)-3-TETRAHYDROFURANYL]OXY]-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-{[(2R,3S,4S,5R)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
4-O-b-D-Galactopyranosyl-D-fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-Î’-D-galactopyranosyl-D-fructofuranose
4-O-Î’-D-galactopyranosyl-D-fructose
ACILAC
Amivalex
Bifiteral
Cephulac
CEPHULAC SYRUP
CHOLAC
Chronulac
CONSTILAC
|
CONSTULOSE
delta-Lactulose
D-Lactulose
Duphalac
DUPHALAC DRY
E966
ENULOSE
EVALOSE
GENERLAC
HEPTALAC
Lactulosa
Lactulose
LACTULOSE JP17
Lactulosum
LAXILOSE
LAXOSE ORANGE
LEMLAX
Normase
OSMOLAX
PORTALAC
REGULOSE
|
|
17 |
|
Norelgestromin |
Approved, Investigational |
Phase 4 |
|
53016-31-2 |
13752005 9568628 |
Synonyms:
17-Deacetylnorgestimate
17-DEACYLNORGESTIMATE
18-Methylnorethindrone oxime
DEACETYLNORGESTIMATE
D-Norgestrel 3-oxime
EVRA
Levonorgestrel 3-oxime
Levonorgestrel oxime
Levonorgestrel oxime, (3E,17alpha)-isomer
|
Levonorgestrel oxime, (3Z,17alpha)-isomer
LNGO
NORELGESTROMIN
Norelgestromina
Norplant 3-oxime
ORTHO EVRA
Progestin norelgestromin
RWJ-10553
|
|
18 |
|
Vildagliptin |
Approved, Investigational |
Phase 4 |
|
274901-16-5 |
6918537 |
Synonyms:
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
EQUA
Galvus
Galvus®|LAF-237|NVP-LAF237
Jalra
LAF 237
LAF237
LAF-237
|
NVP LAF237
NVP-LAF 237
NVP-LAF237
NVP-LAF-237
Vildagliptin
Vildagliptina
Xiliarx
|
|
19 |
|
Gliclazide |
Approved |
Phase 4 |
|
21187-98-4 |
3475 |
Synonyms:
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulphonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulphonyl)urea
Alphapharm brand OF gliclazide
BILXONA
DACADIS MR
Diabrezide
Diaglyk
Diaikron
Diamicron
DIAMICRON MR
EDICIL
Gen gliclazide
Generics brand OF gliclazide
Gen-gliclazide
Genpharm brand OF gliclazide
GLICLAZIDA
Gliclazida [INN-Spanish]
GLICLAZIDE
Gliclazide servier brand
GLICLAZIDUM
Gliclazidum [INN-Latin]
Gliklazid
|
Glimicron
GLIMIL
Glyade
Glyclazide
Helsinn brand OF gliclazide
J3.151H
Mylan-Gliclazide
N-(4-Methylbenzenesulfonyl)-n'-(3-azabicyclo(3.3.0)oct-3-yl)urea
NAZDOL MR
Nordialex
novo Gliclazide
novo-Gliclazide
Novopharm brand OF gliclazide
PMS-Gliclazide
S-1702
S-852
SE-1702
Servier brand OF gliclazide
VAMJU
VITILE XL
ZICLASEG
ZICRON
ZICRON PR
|
|
20 |
|
Strontium ranelate |
Approved, Withdrawn |
Phase 4 |
|
135459-87-9 |
|
21 |
|
Raloxifene |
Approved, Investigational |
Phase 4 |
|
82640-04-8, 84449-90-1 |
5035 |
Synonyms:
(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone
Eviden
EVIREX
Evista
Evista®|LY-156758|Optruma®|raloxifene hydrochloride
J22.982B
Keoxifene
KEOXIFENE HCL
Keoxifene hydrochloride
LY 139481
LY-139481
LY156758
LY-156758
|
OPTRUMA
OSTIRAL
RAL
Raloxifene
Raloxifène
Raloxifene HCL
Raloxifene hydrochloride
Raloxifeno
Raloxifeno [Spanish]
Raloxifenum
Raloxifenum [Latin]
Raxeto
RAZYLAN
|
|
22 |
|
Sodium fluoride |
Approved |
Phase 4 |
|
7681-49-4 |
|
Synonyms:
Fluoride, sodium
Fluorides, sodium
Fluorinse
Fluoristat
Fluoristats
NaF
Ossin
|
Ossins
Procter and gamble brand OF sodium fluoride
Sodium fluoride
Sodium fluorides
Zymafluor
Zymafluors
|
|
23 |
|
Etonogestrel |
Approved, Investigational |
Phase 4 |
|
54048-10-1 |
6917715 |
Synonyms:
13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
3-Ketodesogestrel
3-Keto-desogestrel
3-oxo Desogestrel
3-Oxodesogestrel
ETONOGESTREL
ÉTONOGESTREL
|
Etonogestrelum
Implanon
Nexplanon
Nourypharma brand OF 3-keto-desogestrel
ORG-3236
Organon brand OF 3-keto-desogestrel
|
|
24 |
|
Desogestrel |
Approved |
Phase 4 |
|
54024-22-5 |
40973 |
Synonyms:
13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol
13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17a-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol
AIZEA
alpha-Pregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-18,19-dinor-17
Cerazette
CERELLE
Desogestrel
|
Désogestrel
Desogestrelum
DESOMONO
FEANOLLA
Marvelon
NACREZ
ORG-2969
Organon brand OF desogestrel
ZELLETA
|
|
25 |
|
Metformin |
Approved |
Phase 4 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
26 |
|
Dapagliflozin |
Approved |
Phase 4 |
|
461432-26-8 |
9887712 |
Synonyms:
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
BMS-512148
BMS-512148|Farxiga®|Forxiga®
BMS-512148-05
|
Dapagliflozin
Dapagliflozina
FARXIGA
FORXIGA
|
|
27 |
|
Teriparatide |
Approved, Investigational |
Phase 4 |
|
52232-67-4 |
16133850 155817470 |
Synonyms:
FORSTEO
Forsteo®|Forteo®|PTH-(1-34) (human)
FORTEO
LY 333334
LY333334
LY-333334
PTH (1-34)
|
PTH 1-34
PTH134
Teriparatida
Teriparatide
Teriparatide recombinant human
ZT-034
|
|
28 |
|
Racivir |
Approved, Investigational |
Phase 4 |
|
143491-57-0, 143491-54-7 |
60877 |
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(−)-(2R,5S)-5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(−)-2'-DEOXY-5-FLUORO-3'-THIACYTIDINE
(-)-b-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-Amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(−)-CIS-4-AMINO-5-FLUORO-1-(2-HYDROXYMETHYL-1,3-OXATHIOLAN-5-YL)-(1H)-PYRIMIDIN-2-ONE
(-)-Emtricitabine
(-)-FTC
(−)-FTC
(-)-Î’-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(−)-Β-2',3'-DIDEOXY-5-FLUORO-3'-THIACYTIDINE
(+/-)-Emtricitabine
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
2'-DEOXY-5-FLUORO-3'THIACYTIDINE
4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
|
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
524W91
524-W-91
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
ABBR FTC
Beta L 2',3' Dideoxy 5 fluoro 3' thiacytidine
beta-L-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
BW-524W91
Coviracil
EMTRICITABIN
EMTRICITABINA
Emtricitabine
EMTRICITABINUM
Emtriva
FTC
FTC-(-)
RCV
|
|
29 |
|
Ritonavir |
Approved, Investigational |
Phase 4 |
|
155213-67-5 |
392622 |
Synonyms:
538, ABT
A-84538
A-84538|ABBOTT-84538|ABT 538|ABT-538|Norvir®|RTV
Abbott 84538
ABBOTT-84538
ABT 538
ABT-538
|
N-[(1S,3S,4S)-1-BENZYL-3-HYDROXY-5-PHENYL-4-{[(1,3-THIAZOL-5-YLMETHOXY)CARBONYL]AMINO}PENTYL]-N~2~-(METHYL{[2-(1-METHYLETHYL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)-L-VALINAMIDE
Norvir
Norvir Sec
NSC-693184
Ritonavir
RITONAVIR RELATED COMPOUNDS MIXTURE
Ritonavirum
|
|
30 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
31 |
|
Ergocalciferol |
Approved, Nutraceutical |
Phase 4 |
|
50-14-6 |
5280793 |
Synonyms:
(+)-Vitamin D2
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3Î’,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
Activated ergosterol
beta-Ol
Buco-D
Calciferol
CALCIFEROL IN ARACH OIL
Calciferols
Calciferon 2
CALTRATE
Condacaps
Condocaps
Condol
Crtron
Crystallina
D2, Vitamin
Daral
D-Arthin
Davitamon D
Davitin
Decaps
Dee-osterol
Dee-ron
Dee-ronal
Dee-roual
delta-Arthin
Deltalin
delta-Tracetten
De-rat concentrate
Deratol
Detalup
D-FORTE
Diactol
Divit urto
Doral
Drisdol
D-Tracetten
ECIFEROL D2
Ercalciol
|
Ergocalciferol
ERGOCALCIFÉROL
Ergocalciferol oil
Ergocalciferols
Ergocalciferolum
ERGO-D2
ERGORAL D2
Ergorone
Ergosterol activated
Ergosterol irradiated
Ertron
Fortodyl
Geltabs
Hi-deratol
Infron
Irradiated ergosta-5,7,22-trien-3beta-ol
LANES
Metadee
Mina D2
Mulsiferol
Mykostin
Novovitamin-D
NSC-62792
Oleovitamin D
OLEOVITAMIN D, SYNTHETIC
Oleovitamin D2
Osteil
Ostelin
OSTO-D2
Radiostol
Radstein
Radsterin
Rodine C
Shock-ferol
Shock-ferol sterogyl
Sterogyl
STEROGYL 15H
STEROGYL-15
Synthetic vitamin D
Uvesterol D
Uvesterol-D
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in oil
VITAMIN D
Vitamin D 2
Vitamin D2
Vitamina D2
Vitavel-D
|
|
32 |
|
Alfacalcidol |
Approved, Nutraceutical |
Phase 4 |
|
41294-56-8 |
5282181 |
Synonyms:
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1a,3b-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1α,3β-diol
1 alpha-Hydroxycholecalciferol
1 alpha-Hydroxyvitamin D3
1a-Hydroxycholecalciferol
1a-Hydroxyvitamin D3
1a-Hydroxy-vitamin D3
1a-Hydroxyvitamin D3 / 1a-hydroxycholecalciferol
1alpha-Hydroxycholecalciferol
1alpha-Hydroxyvitamin D3
1alpha-Hydroxy-vitamin D3
1alpha-OHD3
1-alpha-Oxycholecalciferol
1-Hydroxycholecalciferol
1-Hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer
1-Hydroxycholecalciferol, (1beta)-(5Z)-isomer
1-Hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer
1-Hydroxycholecalciferol, aluminum salt
1Α-hydroxycholecalciferol
|
1Α-hydroxyvitamin D3
1Α-hydroxy-vitamin D3
1Α-hydroxyvitamin D3 / 1α-hydroxycholecalciferol
9,10-Secocholesta-5,7,10(19)-triene-1a,3b-diol
9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol
9,10-Secocholesta-5,7,10(19)-triene-1α,3β-diol
Alfacalcidol
Alfacalcidolum
AlfaD
Alphacalcidol
Alsiodol
Bondiol
Doss brand OF alfacalcidol
Eenalfadrie
EinsAlpha
Etalpha
Oksidevit
One-Alpha
Un-alfa
|
|
33 |
|
Calcitriol |
Approved, Nutraceutical |
Phase 4 |
|
32222-06-3 |
5280453 |
Synonyms:
(1a,3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1R,3S,5Z)-5-{2-[(1R,3AS,4E,7AR)-1-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXANE-1,3-DIOL
(1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1Α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha, 25 Dihydroxy 20 epi vitamin D3
1 alpha, 25-Dihydroxy-20-epi-vitamin D3
1 alpha,25 Dihydroxycholecalciferol
1 alpha,25 Dihydroxyvitamin D3
1 alpha,25-Dihydroxycholecalciferol
1 alpha,25-Dihydroxyvitamin D3
1,25 Dihydroxy 20 epi vitamin D3
1,25 Dihydroxycholecalciferol
1,25 Dihydroxyvitamin D3
1,25(OH)2-20EPi-D3
1,25-DHCC
1,25-Dihydroxy-20-epi-vitamin D3
1,25-Dihydroxycholecalciferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1a,25(OH)2D3
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1a,25-Dihydroxyvitamin D3 / 1a,25-dihydroxycholecalciferol / calcitriol
1-a-25-Dihydroxyvitamin D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1Α,25(OH)2D3
1Α,25-dihydroxycholecalciferol
1Α,25-dihydroxyvitamin D3
1Α,25-dihydroxyvitamin D3 / 1α,25-dihydroxycholecalciferol / calcitriol
1-Α-25-dihydroxyvitamin D3
20 Epi 1alpha,25 dihydroxycholecaliferol
20-Epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
Abbott brand OF calcitriol
alpha,25-Dihydroxyvitamin D3, 1
Alphapharm brand OF calcitriol
Bocatriol
Calcijex
Calcijex®|calcitriol|Rocaltrol®
|
Calcitriol
Calcitriol abbott brand
Calcitriol alphapharm brand
Calcitriol cryopharma brand
Calcitriol galderma brand
Calcitriol gry brand
Calcitriol jenapharm brand
Calcitriol kyramed
Calcitriol kyramed brand
Calcitriol leo brand
Calcitriol medice brand
Calcitriol nefro
Calcitriol renacare brand
Calcitriol roche brand
Calcitriol-nefro
CalcitriolNefro
Calcitriolum
Cryopharma brand OF calcitriol
D3, 1 alpha,25-Dihydroxyvitamin
D3, 1,25-Dihydroxy-20-epi-vitamin
D3, 1,25-Dihydroxyvitamin
Decostriol
DIHYDROXYCHOLECALCIFEROL
DIHYDROXYVITAMIN D 3
Dihydroxyvitamin D3
Galderma brand OF calcitriol
Gry brand OF calcitriol
Hoffmann la roche brand OF calcitriol
Hoffmann-la roche brand OF calcitriol
Jenapharm brand OF calcitriol
KyraMed brand OF calcitriol
KyraMed, calcitriol
Leo brand OF calcitriol
Medice brand OF calcitriol
Osteotriol
RenaCare brand OF calcitriol
Renatriol
Ro 21-5535
RO-215535
RO-21-5535
Rocaltrol
Roche brand OF calcitriol
Silkis
Sitriol
Soltriol
Tirocal
Topitriol
Toptriol
VECTICAL
|
|
34 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
35 |
|
Sofosbuvir-velpatasvir drug combination |
|
Phase 4 |
|
|
|
36 |
|
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination |
|
Phase 4 |
|
|
|
37 |
|
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination |
|
Phase 4 |
|
|
|
38 |
|
Emtricitabine tenofovir alafenamide |
|
Phase 4 |
|
|
|
39 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
40 |
|
Expectorants |
|
Phase 4 |
|
|
|
41 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
42 |
|
Citrate |
|
Phase 4 |
|
|
|
43 |
|
Mitogens |
|
Phase 4 |
|
|
|
44 |
|
Contraceptives, Oral, Combined |
|
Phase 4 |
|
|
|
45 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
46 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
47 |
|
Vitamin D2 |
|
Phase 4 |
|
|
3249 |
Synonyms:
Calciferols
D2, Vitamin
Ergocalciferol
|
Ergocalciferols
Vitamin D 2
Vitamin D2
|
|
48 |
|
Ergocalciferols |
|
Phase 4 |
|
|
|
49 |
|
Hepcidins |
|
Phase 4 |
|
|
|
50 |
|
Olive |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 529)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Switch Followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy Followed by Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Simplification in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy - A Pilot Feasibility Study |
Unknown status |
NCT03549312 |
Phase 4 |
Genvoya;Epclusa;Biktarvy |
2 |
The Impact of Serum Vitamin D and Calcium Levels on the Body Composition, Bone Mineral Density, Muscle Strength, Exercise Tolerance, Fatigue and Inflammatory Activity in Patients With Crohn's Disease: a Randomized Controlled Trial |
Unknown status |
NCT02704624 |
Phase 4 |
|
3 |
Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Disodium Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant |
Completed |
NCT00657852 |
Phase 4 |
Disodium pamidronate;Placebo |
4 |
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients |
Completed |
NCT02999204 |
Phase 4 |
Vitamin D3 |
5 |
A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients |
Completed |
NCT00157690 |
Phase 4 |
Alendronate;Placebo |
6 |
A Randomized Placebo Controlled Double Blind Investigation of the Effects of Potassium Citrate on Bone Metabolism in Postmenopausal Osteopenia |
Completed |
NCT00357331 |
Phase 4 |
potassium citrate |
7 |
Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial |
Completed |
NCT02853539 |
Phase 4 |
Denosumab |
8 |
Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER): A Multicenter, Double-blind, Randomized, Placebo-controlled Trial |
Completed |
NCT02214563 |
Phase 4 |
|
9 |
Regenerative Potential of a Collagen Membrane Associated or Not to Bovine Bone in Class II Furcation Defects - A Randomized Clinical Trial. |
Completed |
NCT04450849 |
Phase 4 |
|
10 |
A 6 Months, Open-Label Phase IV Study to Confirm the Safety and Efficacy of Single Intravenous Dose of 5 mg Zoledronic Acid for the Patients of Paget's Disease of Bone (PDB) in China |
Completed |
NCT00774020 |
Phase 4 |
Zoledronic acid |
11 |
An Open Label, Reclast®/Aclasta®, Re-treatment of Relapsed Patients With Paget's Disease of Bone Who Participated in the CZOL446K2304 and CZOL446K2305 Core Registration Studies |
Completed |
NCT00740129 |
Phase 4 |
Zoledronic Acid |
12 |
Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients: A Prospective, Randomized Placebo-controlled Double Blind Trial |
Completed |
NCT02976246 |
Phase 4 |
|
13 |
Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty. A Randomized, Double-blind, Placebo-controlled, Parallel-group Study |
Completed |
NCT00772395 |
Phase 4 |
Risedronate;Placebo |
14 |
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation |
Completed |
NCT00668200 |
Phase 4 |
Reclast (ZOL446, zoledronic acid) |
15 |
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate |
Completed |
NCT02604836 |
Phase 4 |
Ibandronate |
16 |
An Open-Label, Multi-Center Study to Determine Level of Adherence to Monthly Oral or Every Three Month Intravenous Ibandronate Treatment in Post-Menopausal Women With Osteoporosis or Osteopenia, Who Are GI Intolerant of Daily or Weekly Alendronate or Risendronate |
Completed |
NCT02598453 |
Phase 4 |
Ibandronate |
17 |
An Open Label Study of the Efficacy, Safety, and Pharmacoeconomics of Oral Ibandronate (Bondronat 50 mg) in Treatment of Metastatic Bone Disease |
Completed |
NCT02564107 |
Phase 4 |
Ibandronate |
18 |
A 2 Year Prospective, Multicentre, Open-label, Randomised, Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients (With a PTH > 150pg/ml) on a Ciclosporin A and Glucocorticoid Based Immunosuppressive Regimen. |
Completed |
NCT00738257 |
Phase 4 |
Pamidronate |
19 |
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal |
Completed |
NCT00504166 |
Phase 4 |
alendronate sodium |
20 |
High Dosage Vitamin D in the Treatment of Osteoporosis in Postmenopausal Women |
Completed |
NCT00491920 |
Phase 4 |
cholecalciferol (Vitamin D3);placebo |
21 |
A Multinational, Randomized, Double-Blind, Parallel Group Comparative Trial on the Effects of 2 Years Treatment With Tibolone (1.25 mg Org OD 14) and Raloxifene (60 mg) on Bone Mineral Density in Osteopenic Postmenopausal Women |
Completed |
NCT00431431 |
Phase 4 |
tibolone;raloxifen |
22 |
A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant System Over 24 Months, for Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol |
Completed |
NCT01960361 |
Phase 4 |
|
23 |
A Multi-center, Randomized, Double-blind, Double-dummy Study in Postmenopausal Women With Low Bone Mineral Density to Compare the Effects of a Single Dose of i.v. Zoledronic Acid 5 mg, With Daily Oral Raloxifene 60 mg OD on Bone Turnover Markers |
Completed |
NCT00431444 |
Phase 4 |
Raloxifene;Zoledronic acid;Placebo oral pills;Placebo intravenous (i.v.) infusion |
24 |
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? |
Completed |
NCT00766532 |
Phase 4 |
Aromatase Inhibitor |
25 |
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid |
Completed |
NCT00172029 |
Phase 4 |
Zoledronic acid |
26 |
Bisphosphonate Therapy for Osteogenesis Imperfecta |
Completed |
NCT00159419 |
Phase 4 |
Alendronate;Pamidronate |
27 |
The P.O.W.E.R. STUDY (Premenopause, Osteopenia/Osteoporosis, Women, Alendronate, Depression) |
Completed |
NCT00006180 |
Phase 4 |
Alendronate |
28 |
Does Treatment of Hypovitaminosis D Increase Calcium Absorption? |
Completed |
NCT00581828 |
Phase 4 |
Vitamin D |
29 |
Switch From Tenofovir to Raltegravir for Low Bone Mineral Density |
Completed |
NCT00939874 |
Phase 4 |
Raltegravir |
30 |
A Randomized, Double-Blind, Multicenter, Parallel Pilot Clinical Trial to Study the Efficay of a Treatment of Lactulose + Vitamin D + Calcium 0.5 g Concurrently Controlled With a Standard Treatment (Vit D + Calcium) in Bone Mass Preservation Among Postmenopausal Women |
Completed |
NCT00160264 |
Phase 4 |
Lactulose, Vitamin D, Calcium |
31 |
Osteopenia and Renal Osteodystrophy: Evaluation and Management |
Completed |
NCT00108394 |
Phase 4 |
pamidronate |
32 |
Influence of Alfacalcidol on Falls in Elderly Postmenopausal, Alendronate-Treated, Osteopenic/Osteoporotic Women With High Risk of Falls |
Completed |
NCT00168909 |
Phase 4 |
alfacalcidol;placebo |
33 |
Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis |
Completed |
NCT00164008 |
Phase 4 |
zoledronic acid vs pamidronate |
34 |
Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia |
Completed |
NCT00129623 |
Phase 4 |
Placebo;ibandronate [Bonviva/Boniva] |
35 |
Primary Mechanisms Underlying the Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis and Bone Metabolism in Young Women |
Completed |
NCT02367833 |
Phase 4 |
Combined Oral Contraceptive;Transdermal Contraceptive;Contraceptive Vaginal Ring |
36 |
An International Multicentric, Multidisciplinary Prospective and Randomized Study to Compare Minimally Invasive Reduction and Fixation Using the KyphX System and Radiopaque PMMA Cement to Medical Therapy Alone for the Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures |
Completed |
NCT00211211 |
Phase 4 |
|
37 |
Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR |
Completed |
NCT01679899 |
Phase 4 |
Vildagliptin;Gliclazide MR |
38 |
An Open, Prospective, Multi-center Study to Evaluate Bone Loss, the Survival Rate of SPI Implant System and Implant Stability Over a 24 Months, in Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol. |
Completed |
NCT02367261 |
Phase 4 |
|
39 |
Efficacy of Monthly Ibandronate in Women With Rheumatoid Arthritis and Reduced Bone Mineral Density Receiving Long-term Glucocorticoids |
Completed |
NCT01287533 |
Phase 4 |
Ibandronate;Placebo |
40 |
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium- and Bone Metabolism After Successful Surgery? - Part I |
Completed |
NCT01222026 |
Phase 4 |
Strontium Ranelate + Ca/Vitamin-D;Placebo |
41 |
A Randomized, Data Collection Program To Determine the Efficacy and Safety of Risedronate (Actonel) Therapy Plus Calcium and Vitamin D Supplementation Versus Placebo Plus Calcium and Vitamin D Supplementation in the Treatment of Low Bone Mineral Density in Crohn's Disease Patients |
Completed |
NCT01215890 |
Phase 4 |
risedronate;placebo |
42 |
NMR Imaging and Stereological Analysis of Trabecular Bone in Female Subjects 60 and Older at Risk of Fracture Receiving Either Zoledronic Acid or Teriparatide |
Completed |
NCT01153425 |
Phase 4 |
Teriparatide;Zoledronic Acid |
43 |
Study of Vitamin D2 Virus 1,25(OH)2-Vitamin D3 in the Treatment of Chronic Kidney Disease Mineral and Bone Disease |
Completed |
NCT01633853 |
Phase 4 |
Vitamin D2;1,25(OH)2 Vit D3 |
44 |
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. |
Completed |
NCT00365131 |
Phase 4 |
Cerezyme (imiglucerase for injection) |
45 |
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery |
Recruiting |
NCT04087096 |
Phase 4 |
Denosumab;Placebo;Zoledronic Acid |
46 |
A Randomized, Double-blind Study of the Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum Vitamin D Levels in Pediatric Patients With Cystic Fibrosis |
Recruiting |
NCT05276960 |
Phase 4 |
Cholecalciferol Pill |
47 |
Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa |
Recruiting |
NCT05141838 |
Phase 4 |
Vitamin D |
48 |
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Patients With Chronic Kidney Disease |
Recruiting |
NCT04522622 |
Phase 4 |
Teriparatide |
49 |
Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia: an 1-year Randomized Controlled Trial |
Recruiting |
NCT05386784 |
Phase 4 |
Raloxifene plus cholecalciferol;Cholecalciferol |
50 |
The Effect of Oral vs. Non-oral Contraceptive Therapy on Bone Turnover Using 41Ca Methodology |
Active, not recruiting |
NCT02367846 |
Phase 4 |
Combined Oral Contraceptive (COC);Contraceptive Vaginal Ring (CVR) |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Cochrane evidence based reviews: bone diseases
|